Back to Sites

Baylor-Uganda CRS

Site Number

31798

Address

Baylor College of Medicine Children's Foundation-Uganda
Block 5 Mulago Hospital
PO Box 72052
Kampala,
Uganda

IMPAACT Members at this Site

Violet Korutaro CRS Coordinator

Adeodata Kekitiinwa CRS Leader

Mahnaz Motevalli-Oliner CTU Coordinator

Mary Glenn Fowler CTU Principal Investigator

Philippa Musoke CTU Principal Investigator

Aaron Tobian CTU Principal Investigator

Pauline Amuge Investigator

Victoria Ndyanabangi Investigator

Lilian Birungi Study Coordinator

Beatrice Nagaddya Study Coordinator

Studies at this Site

P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

11954

Research Area

Cure and Immunotherapy

Study Status

Enrolling

IMPAACT 2009 : Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention during Pregnancy and Postpartum in Adolescents and Young Women and their Infants

DAIDS Number

30020

Research Area

Therapeutics

Study Status

Closed to Follow Up

IMPAACT 2010: VESTED

DAIDS Number

30129

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

DAIDS Number

38609

Research Area

Therapeutics

Study Status

Enrolling

IMPAACT 2024 : Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV

DAIDS Number

38747

Research Area

Tuberculosis

Study Status

In Development

IMPAACT 2028: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV

DAIDS Number

38693

Research Area

Cure and Immunotherapy

Study Status

Enrolling

IMPAACT 2017: MOCHA

DAIDS Number

30070

Research Area

Therapeutics

Study Status

Closed to Accrual